Sign Up to like & get
recommendations!
1
Published in 2020 at "Pediatric Critical Care Medicine"
DOI: 10.1097/pcc.0000000000002433
Abstract: 928 www.pccmjournal.org October 2020 • Volume 21 • Number 10 response in premature infants with mild-to-moderate respiratory distress. In this regard, we agree with the comment by Madney et al (1) that the experimental period…
read more here.
Keywords:
role;
pediatric intensivist;
intensivist coronavirus;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Respiratory Research"
DOI: 10.1186/s12931-019-1096-9
Abstract: BackgroundNon-invasive delivery of nebulized surfactant has been a neonatology long-pursued goal. Nevertheless, the clinical efficacy of nebulized surfactant remains inconclusive, in part, due to the great technical challenges of depositing nebulized drugs in the lungs…
read more here.
Keywords:
poractant alfa;
delivery;
nebulized surfactant;
delivery strategy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_201912_19811
Abstract: OBJECTIVE This study aimed to evaluate effect of budesonide combining Poractant Alfa on preventing bronchopulmonary dysplasia (BPD). PATIENTS AND METHODS A total of 120 preterm infants were involved. pH value, partial pressure of oxygen (PO2),…
read more here.
Keywords:
sirt1;
bronchopulmonary dysplasia;
poractant alfa;
group ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2017.00186
Abstract: Background Poractant alfa (Curosurf®) and Bovactant (Alveofact®) are two animal-derived pulmonary surfactants preparations approved for the treatment of neonatal respiratory distress syndrome (nRDS). They differ in their source, composition, pharmaceutical form, and clinical dose. How…
read more here.
Keywords:
poractant alfa;
alfa;
respiratory distress;
preterm lambs ... See more keywords